Skip to main content
Premium Trial:

Request an Annual Quote

UK Invests $97M in London Translational Research Center

NEW YORK (GenomeWeb News) – The UK government has awarded £58.7 million ($96.7 million) to a research center at King's College London and Guy's and St. Thomas', a National Health Service trust with two hospitals in London, that will engage in translational research, including biomarker and drug discovery studies.

The Biomedical Research Centre will use the five-year funding to establish the School of Translational and Experimental Medicine and to capitalize upon earlier investments made in new facilities and training programs, according to Guy's and St. Thomas'.

"We will focus on pulling through early discovery of new drugs, molecules and biomarkers into the clinic – and then extending these beyond the hospital and into the wider community through close collaboration with primary care," Guy's and St. Thomas' Chief Executive Ron Kerr said in a statement. "Our scientists and clinicians are at the forefront of developing some of the latest diagnostic techniques and therapeutics so that we can tailor both diagnosis and treatment to individual patients."

The new funding for the Centre was part of a new round of £112 million for research from the National Institute of Health Research that includes £53.3 million to establish mental health research centers.

Filed under

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.